Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA Challenge in Late-Life Depression
NCT06626152Phase 2Recruiting
- Sponsor
- University of British Columbia
- Start
- Aug 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa in major depressive disorder (MDD), sponsored by University of British Columbia. Started Aug 2024; status: recruiting.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06626152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06626152.